يعرض 1 - 10 نتائج من 16 نتيجة بحث عن '"Kolstad AT"', وقت الاستعلام: 1.53s تنقيح النتائج
  1. 1
    Lenalidomide-bendamustine-rituximab in patients older than 65 years with untreated mantle cell lymphoma

    المؤلفون: Mats Ehinger, Kirsten Grønbæk, Alexandra Albertsson-Lindblad, Christian H. Geisler, Mats Jerkeman, Anna Laurell, Lone Bredo Pedersen, Marja-Liisa Karjalainen-Lindsberg, J. Sundberg, Arne Kolstad, Riikka Räty, Christer Sundström, Elisabeth Ralfkiaer

    المصدر: Blood. 128(14)

    مصطلحات موضوعية: Bendamustine, Male, medicine.medical_specialty, Neoplasm, Residual, Immunology, Lymphoma, Mantle-Cell, Biochemistry, Gastroenterology, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, International Prognostic Index, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Bendamustine Hydrochloride, Humans, Progression-free survival, Lenalidomide, Aged, Aged, 80 and over, business.industry, Cell Biology, Hematology, Middle Aged, medicine.disease, 3. Good health, Surgery, CD4 Lymphocyte Count, Thalidomide, Treatment Outcome, 030220 oncology & carcinogenesis, Rituximab, Mantle cell lymphoma, Female, Cytomegalovirus retinitis, Every Four Weeks, business, Tomography, X-Ray Computed, 030215 immunology, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dd7767814df18bdcb8e6c834b85b9c6
    https://pubmed.ncbi.nlm.nih.gov/28832328

    أضف إلى المفضلة
  2. 2
    The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT)

    المؤلفون: Marja-Liisa Karjalainen-Lindsberg, Anne Marie Boesen, Mats Jerkeman, Riikka Räty, Christian H. Geisler, Eva Kimby, Anna Laurell, Grete F. Lauritzsen, Mats Ehinger, Marie Nordström, Erkki Elonen, Christer Sundström, Arne Kolstad, Elisabeth Ralfkiaer, Outi Kuittinen, Jan Delabie, Peter de Nully Brown, Herman Nilsson-Ehle, Mikael Eriksson

    المصدر: Blood. 115:1530-1533

    مصطلحات موضوعية: Male, Oncology, medicine.medical_specialty, Immunology, Lymphoma, Mantle-Cell, Transplantation, Autologous, Biochemistry, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, Autologous stem-cell transplantation, International Prognostic Index, Risk Factors, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Humans, Medicine, Survival rate, Hematology, business.industry, Cell Biology, medicine.disease, Chemotherapy regimen, 3. Good health, Lymphoma, Surgery, Gene Expression Regulation, Neoplastic, Survival Rate, Transplantation, Ki-67 Antigen, 030220 oncology & carcinogenesis, Female, Mantle cell lymphoma, business, Stem Cell Transplantation, 030215 immunology

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3901f47a4dbf9eb2c87cec5baaa8bf67
    https://doi.org/10.1182/blood-2009-08-236570

    أضف إلى المفضلة
  3. 3
    Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo–purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group

    المؤلفون: Marie Nordström, Outi Kuittinen, R. Langholm, Marja-Liisa Karjalainen-Lindsberg, Jan Delabie, Anne Marie Boesen, Erkki Elonen, Mikael Eriksson, Mats Jerkeman, Arne Kolstad, Lone Bredo Pedersen, Christer Sundström, Peter de Nully Brown, Herman Nilsson-Ehle, Mats Ehinger, Grete F. Lauritzsen, Elisabeth Ralfkiaer, Måns Åkerman, Christian H. Geisler, Eva Kimby, Niels Smedegaard Andersen, Anna Laurell

    المصدر: Blood. 112:2687-2693

    مصطلحات موضوعية: Adult, Male, Oncology, Vincristine, medicine.medical_specialty, Time Factors, Clinical Trials and Observations, medicine.medical_treatment, Immunology, Lymphoma, Mantle-Cell, Biochemistry, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Humans, Progression-free survival, Etoposide, Aged, Chemotherapy, business.industry, Stem Cells, Bone Marrow Purging, Cell Biology, Hematology, Middle Aged, medicine.disease, Combined Modality Therapy, 3. Good health, Surgery, Transplantation, Ki-67 Antigen, Treatment Outcome, 030220 oncology & carcinogenesis, Multivariate Analysis, Cytarabine, Refractory Mantle Cell Lymphoma, Female, Mantle cell lymphoma, Immunotherapy, business, 030215 immunology, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f62ffe47753420d1c3cb904d83db1eb
    https://doi.org/10.1182/blood-2008-03-147025

    أضف إلى المفضلة
  4. 4
    Ibrutinib-Lenalidomide-Rituximab in Patients with Relapsed/Refractory Mantle Cell Lymphoma: First Results from the Nordic Lymphoma Group MCL6 (PHILEMON) Phase II Trial

    المؤلفون: Hanne Kuitunen, Riikka Räty, Kirsten Grønbæk, Lone Bredo Pedersen, Arne Kolstad, Anna Laurell, Mats Jerkeman, Helle Toldbod, Christian Winther Eskelund, Christian H. Geisler, Karin Fahl Wader, Martin Hutchings, Carsten Utoft Niemann

    المصدر: Blood. 128:148-148

    مصطلحات موضوعية: medicine.medical_specialty, Immunology, Neutropenia, Biochemistry, Gastroenterology, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, medicine, Lenalidomide, business.industry, Cell Biology, Hematology, medicine.disease, Minimal residual disease, Chemotherapy regimen, 3. Good health, Surgery, Regimen, chemistry, 030220 oncology & carcinogenesis, Ibrutinib, Rituximab, Mantle cell lymphoma, business, 030215 immunology, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::4d4777ae86ae0abbdacfe2bd1cd6d1c9
    https://doi.org/10.1182/blood.v128.22.148.148

    أضف إلى المفضلة
  5. 5
    177lu-Satetraxetan-Lilotomab in the Treatment of Patients with Indolent Non-Hodgkin B-Cell Lymphoma (NHL), Phase 1/2 Safety and Efficacy Data from Four Different Pre-Dosing Regimens

    المؤلفون: Jostein Dahle, Arne Kolstad, Simon Turner, Åse Østengen, Martin Erlanson, Jon Erik Holtedahl, Laurie Baylor Curtis, Signe Spetalen, Nils Bolstad, Caroline Stokke, Matthew Beasley, Mona-Elisabeth Revheim, Ulf Madsbu, Michael Bayne, Noelle O'Rourke, Timothy M Illidge, Tore Bach-Gansmo, Øyvind S. Bruland, Ayca Løndalen, Stine Nygaard Rudå, Harald Holte, Roy H. Larsen

    المصدر: Blood. 128:1780-1780

    مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Immunology, Neutropenia, Biochemistry, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, B-cell lymphoma, Adverse effect, business.industry, Cell Biology, Hematology, medicine.disease, Interim analysis, Surgery, Lymphoma, Regimen, 030104 developmental biology, 030220 oncology & carcinogenesis, Rituximab, business, Progressive disease, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::ae0ae4daf8ab4f3f53e1186fe8f8372f
    https://doi.org/10.1182/blood.v128.22.1780.1780

    أضف إلى المفضلة
  6. 6
    Efficacy and Safety Results of a Phase 1 Study of 177 lu-DOTA-HH1 (Betalutin®) with and without HH1 Pre-Dosing for Patients with Relapsed CD37+ Non-Hodgkin B Cell Lymphoma (NHL)

    المؤلفون: Nils Bolstad, Caroline Stokke, Ulf Madsbu, Jostein Dahle, Mona-Elisabeth Revheim, Jon Erik Holtedahl, Harald Holte, Arne Kolstad, Signe Spetalen, Ayca Løndalen, Roy H. Larsen, Stine Nygaard Rudå, Øyvind S. Bruland, Tore Bach-Gansmo, Martin Erlanson, Bjørg Bolstad

    المصدر: Blood. 126:5118-5118

    مصطلحات موضوعية: medicine.medical_specialty, business.industry, Immunology, Follicular lymphoma, Cell Biology, Hematology, Neutropenia, medicine.disease, Biochemistry, Gastroenterology, Surgery, Platelet transfusion, Refractory, Internal medicine, medicine, Mantle cell lymphoma, Rituximab, business, B-cell lymphoma, Febrile neutropenia, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::f986fba41496239eec438404632cecb9
    https://doi.org/10.1182/blood.v126.23.5118.5118

    أضف إلى المفضلة
  7. 7
    Role Of High-Dose Cytarabine and Total Body Irradiation Conditioning before Autologous Stem Cell Transplantation In Mantle Cell Lymphoma - A Comparison Of Nordic MCL2, HOVON 45, and European MCL Younger Trials

    المؤلفون: Arne Kolstad, Christiane Pott, Martin Dreyling, Mats Jerkeman, Mars B. van 't Veer, Michael Unterhalt, Gilles Salles, Wolfram Klapper, Christian H. Geisler, Jan Walewski, Vincent Ribrag, Anna Laurell, Jeanette K. Doorduijn, Michael Hallek, R. Raty, Stephan Stilgenbauer, Hanneke C. Kluin-Nelemans, Bronno van der Holt, Eva Hoster, Olivier Hermine

    المصدر: Blood. 122:3367-3367

    مصطلحات موضوعية: Oncology, Melphalan, medicine.medical_specialty, Cumulative dose, business.industry, Immunology, Cell Biology, Hematology, Total body irradiation, medicine.disease, Biochemistry, Chemotherapy regimen, Surgery, Autologous stem-cell transplantation, Internal medicine, medicine, Cytarabine, Mantle cell lymphoma, Progression-free survival, business, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::255f48b429242a047075f06a51a592f0
    https://doi.org/10.1182/blood.v122.21.3367.3367

    أضف إلى المفضلة
  8. 8
    Nordic MCL3 Study: Zevalin Combined with High-Dose Chemotherapy Followed by Autologous Stem Cell Support As Late Intensification for Mantle Cell Lymphoma (MCL) Patients < 66 Years Not in CR After Induction Chemoimmunotherapy: No Benefit of Zevalin

    المؤلفون: Kolstad Arne, Erkki Elonen, Herman Nilsson-Ehle, Riikka Räty, Unn-Merete Fagerli, Christer Sundström, Hans Bentzen, Lone Bredo Pedersen, Grete F. Lauritzsen, Marie Nordström, Christian H. Geisler, Elisabeth Ralfkiaer, Jukka Schildt, Henrik Frederiksen, Trond Velde Bogsrud, Anne Kristine Lehmann, Peter de Nully Brown, Per Boye Hansen, Jan Delabie, Anna Laurell, Kamelia Kostova-Aherdan, Mats Ehinger, Marja-Liisa Karjalainen-Lindsberg, Kirsten Grønbæk, Annika Loft, Mats Jerkeman

    المصدر: Kolstad, A, Laurell, A, Jerkeman, M, Grønbæk, K, Elonen, E, Räty, R, Pedersen, LB, Loft, A, Bogsrud, TV, Nordstrøm, M, Hansen, PB, Fagerli, U, Nilsson-Ehle, H, Lauritzsen, GF, Lehmann, AK, Sundstrom, C, Karjalainen-Lindsberg, M, Ralfkiaer, E, Ehinger, M, Delabie, J, Bentzen, H, Schildt, J, Kostova-Aherdan, K, Frederiksen, H, Brown, P D N & Geisler, CH 2012, ' Nordic MCL3 Study: Zevalin Combined with High-Dose Chemotherapy Followed by Autologous Stem Cell Support As Late Intensification for Mantle Cell Lymphoma (MCL) Patients < 66 Years Not in CR After Induction Chemoimmunotherapy: No Benefit of Zevalin ', American Society of Hematology Annual Meeting 2012, Atlanta, Atlanta, GA., United States, 08/12/2012-11/12/2012 .

    مصطلحات موضوعية: Oncology, medicine.medical_specialty, medicine.medical_treatment, Immunology, Ibritumomab tiuxetan, Biochemistry, 03 medical and health sciences, 0302 clinical medicine, Chemoimmunotherapy, Internal medicine, medicine, Chemotherapy, business.industry, Cell Biology, Hematology, medicine.disease, Chemotherapy regimen, 3. Good health, Surgery, Transplantation, 030220 oncology & carcinogenesis, Cytarabine, Mantle cell lymphoma, Rituximab, business, 030215 immunology, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfa8d3f51854d0214111f12fba1327a0
    https://doi.org/10.1182/blood.v120.21.747.747

    أضف إلى المفضلة
  9. 9
    Lenalidomide, Bendamustine, and Rituximab As First-Line Therapy for Patients > 65 Years with Mantle Cell Lymphoma: Results From the Phase I Portion of the Nordic Lymphoma Group MCL4 (LENA-BERIT) Trial

    المؤلفون: Christian H. Geisler, Lone Bredo Pedersen, Kirsten Grønbæk, Riikka Räty, Arne Kolstad, Anna Laurell, Mats Jerkeman

    المصدر: Blood. 118:2700-2700

    مصطلحات موضوعية: Bendamustine, medicine.medical_specialty, business.industry, Immunology, Cell Biology, Hematology, medicine.disease, Biochemistry, Gastroenterology, Surgery, Regimen, Refractory, Internal medicine, Toxicity, Cohort, Medicine, Mantle cell lymphoma, Rituximab, business, medicine.drug, Lenalidomide

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::cc6af5d63289adfc7f61b16a4205eaba
    https://doi.org/10.1182/blood.v118.21.2700.2700

    أضف إلى المفضلة
  10. 10
    Tositumomab and Iodine I-131 Tositumomab for Previously Untreated, Advanced-Stage, Follicular Lymphoma: Median 10 Year Follow-up Results

    المؤلفون: Arne Kolstad, Charles W. Ross, Melissa Tuck, Vanessa C. Williams, Mark S. Kaminski, Richard L. Wahl, Denise Regan, Tina Vleisides, Judith Estes, Thierry Horner

    المصدر: Blood. 114:3759-3759

    مصطلحات موضوعية: medicine.medical_specialty, business.industry, Immunology, Follicular lymphoma, Iodine I 131 Tositumomab, Cell Biology, Hematology, Neutropenia, medicine.disease, Biochemistry, Tositumomab, Grade 1 Follicular Lymphoma, Surgery, International Prognostic Index, Internal medicine, medicine, Mantle cell lymphoma, Refractory Follicular Lymphoma, business, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::a2b8a26f221e69b9b7cc7fd9650bdc22
    https://doi.org/10.1182/blood.v114.22.3759.3759

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء